Please write an 8-10 pages’ long essay analyzing and discussing the following topics following the order of Tasks 1 to 6: 1. Task 1(5 points): Summarize the case. Length suggestion: 1 page. 2. Task 2 (15 points): Identify (list) the ethical issues that have arisen in this case. Please offer some details about each ethical issue (e.g. including what’s occurred, who’s affected, etc.). Length suggestion: 1 page. 3. Task 3 (20 points): Identify (list) all of the stakeholders of the company (i.e., Chimerix) in the case, and discuss each of their viewpoints (e.g., needs, desires, concerns, costs, benefits, power, etc.). Length suggestion: 1-2 pages. 4. Task 4 (20 points): Explain in detail which of the stakeholders should be involved and helpful to solve the ethical issues that have arisen in the case, and why, given their viewpoints. Length suggestion: 1-2 pages. 5. Task 5 (20 points): List all of the ethical theories and principles (i.e., 14 ethical principles under the part “Principles of ethical conduct” from Page 228 in Chapter 8 of the textbook) that are appropriate for solving the ethical issues in this case. Explain in detail why each principle is appropriate for solving the particular ethical issue. Length suggestion: 2 pages. 6. Task 6 (20 points): Using certain ethical theories and principles to recommend a plan of action for the company that will help the company (i.e., Chimerix) remain competitive and avoid such problems in the future. Explain the expected positive and negative consequences of the plan of action you recommend. Length suggestion: 2 pages. You should not conduct outside research for the case analysis. In other words, you should pretend that you are facing exactly the same situation and information presented in the case. 5. Your answer should be specific to the six tasks specified above and follow the order to organize your analysis. Please keep in mind that those topics are actually interconnected. You need to integrate your answers into a report with smooth logic and internal consistency. You are suggested to use appropriate sub-titles to make your paper easier to follow. 6. The analysis must be professionally written. Don’t use bullet or lists. Write your answers in complete sentences. Please conduct spelling check, grammar check, and virus-check before submission. 7. Avoid laundry lists. Focus and organize your analysis. Look for frameworks from the readings or the textbook that help you organize and present your analysis. 8. Consider ‘turning the question’ into the beginning of your answer. That is, if the question is, “What are the key issues?” begin your answer with; “The key issues” (include or are). This may seem simplistic, but is a very effective way to help you focus your answer on the question(s) asked and to earn full credit. Don’t repeat the entire question in your answer. 9. You need to highlight the names of the ethical principles in your paper. 10. Please follow APA format for your writing (URL: APA Format website). Indicate any 3 references you cited in your report. The references list does NOT count for length requirement purpose.MGMT4308
PROJECT ONE “CASE STUDY” INSTRUCTIONS
Case Subject
“The CEO Who Saved a Life and Lost His Job”
Please see the PDF file in the Project One folder.
Project Tasks
Please write an 8-10 pages’ long essay analyzing and discussing the following topics
following the order of Tasks 1 to 6:
1. Task 1(5 points): Summarize the case. Length suggestion: 1 page.
2. Task 2 (15 points): Identify (list) the ethical issues that have arisen in this case. Please
offer some details about each ethical issue (e.g. including what’s occurred, who’s
affected, etc.). Length suggestion: 1 page.
3. Task 3 (20 points): Identify (list) all of the stakeholders of the company (i.e., Chimerix)
in the case, and discuss each of their viewpoints (e.g., needs, desires, concerns, costs,
benefits, power, etc.). Length suggestion: 1-2 pages.
4. Task 4 (20 points): Explain in detail which of the stakeholders should be involved and
helpful to solve the ethical issues that have arisen in the case, and why, given their
viewpoints. Length suggestion: 1-2 pages.
5. Task 5 (20 points): List all of the ethical theories and principles (i.e., 14 ethical
principles under the part “Principles of ethical conduct” from Page 228 in Chapter 8 of
the textbook) that are appropriate for solving the ethical issues in this case. Explain in
detail why each principle is appropriate for solving the particular ethical issue. Length
suggestion: 2 pages.
6. Task 6 (20 points): Using certain ethical theories and principles to recommend a plan of
action for the company that will help the company (i.e., Chimerix) remain competitive
and avoid such problems in the future. Explain the expected positive and negative
consequences of the plan of action you recommend. Length suggestion: 2 pages.
7. You will be given 5 bonus points for sending your draft to UHV writing center to
improve your writing quality. UHV writing center tutoring service is free but
reservation is needed. URL: UHV Writing Center website
2
Guidelines and Requirement
1. The length of your essay is about 8-10 pages (double-spaced, 12 pt “Times New Roman”
font, 1-inch margins, excluding exhibits and references) in MS Word format.
2. Submission deadlines:
a. You need to submit your complete draft by July 5, 2020.
a. Final submission due: July 19, 2020 11:59 PM through TurnItIn submission. Please
submit your final paper a few days before the deadline so that you can have time to
revise if the similarity rate is high. You can have multiple submissions but only your
last attempt will be graded.
3. Before you start, read the instructions and the case twice. You should also read the
other files in the project one folder (on Blackboard) too.
4. You should not conduct outside research for the case analysis. In other words, you
should pretend that you are facing exactly the same situation and information
presented in the case.
5. Your answer should be specific to the six tasks specified above and follow the order to
organize your analysis. Please keep in mind that those topics are actually
interconnected. You need to integrate your answers into a report with smooth logic and
internal consistency. You are suggested to use appropriate sub-titles to make your
paper easier to follow.
6. The analysis must be professionally written. Don’t use bullet or lists. Write your answers
in complete sentences. Please conduct spelling check, grammar check, and virus-check
before submission.
7. Avoid laundry lists. Focus and organize your analysis. Look for frameworks from the
readings or the textbook that help you organize and present your analysis.
8. Consider ‘turning the question’ into the beginning of your answer. That is, if the question
is, “What are the key issues?” begin your answer with; “The key issues” (include or are).
This may seem simplistic, but is a very effective way to help you focus your answer on
the question(s) asked and to earn full credit. Don’t repeat the entire question in your
answer.
9. You need to highlight the names of the ethical principles in your paper.
10. Please follow APA format for your writing (URL: APA Format website). Indicate any
3
references you cited in your report. The references list does NOT count for length
requirement purpose.
11. Not following instructions would result in point deduction.
Grading Standards and Rubrics
In grading your written assignments I use the following standards.
1. Rigor of analysis: You should use the appropriate frameworks from the class that are
germane to the problem.
2. Logical consistency: Your writing should be logically consistent from the beginning to
the end.
3. Depth of analysis and practical implications: Before making your own argument,
consider alternative explanations and solutions. Then try to justify your argument or
identify the situations under which some solutions are working better than others.
4. Clarity of writing: Papers should be addressed to a managerial audience. This means
that you should outline carefully, write clearly and concisely, and use appropriate tables
and graphics to support your argument, if necessary.
Please see attached page for the rubrics used in our course assessment.
Academic Honesty
1. The University’s policies related to academic honesty will be strictly enforced.
2. Your work on this assignment must be entirely your own. Your final submission is
subject to the similarity check by Turnitin.com (with the submission link available in the
project folder later). A submission with 20% or higher similarity rate will receive a
failing score.
3. Situations in which 2 or more students are alleged to have been involved in a conspiracy
to cheat will be referred to the Provost and/or Academic Council as discussed in the
Student Handbook.
4. By completing and submitting this assignment, you acknowledge that you have read, and
have agreed to, the above rules relating to Academic Honesty.
In early 2014, 7-year-old Josh Hardy
was dying. He’d been battling kidney
cancer since he was a baby and survived
10 intensive chemotherapy treatments,
which severely weakened his
immune system. Soon after undergoing
a bone marrow stem cell transplant
last January, he developed a
life-
threatening respiratory virus.
Chimerix, a small biotechnology
company in Durham, N.C., had an
experimental, unapproved drug in
development that might help, Josh’s
doctor at St. Jude Children’s Research
Hospital told the boy’s family. They
twice asked Chimerix to provide Josh
the drug and were refused both times.
“Please help us save our son,” his
mother, Aimee, wrote on her Facebook
page on March 6. “If anyone with
influence can help us convince the
Chimerix Inc to release the drug for
compassionate care for our son, we
would be forever grateful.”
Within several days, a
#SaveJosh hashtag was
trending
on Twitter. A
Facebook page set up for Josh’s
cause registered 27,000 “likes” in one
week. Social media posts supporting
the family’s effort to get the drug were
directed at Chimerix and its chief
executive
officer, Kenneth Moch, who
also received thousands of e-mails and
phone calls. If Josh dies, asked one
tweet, “how will Moch live w/himself?”
Another said that Moch’s decision to
withhold the drug carried “a HEAVY
Karmic price!” Yet another called
Chimerix executives “cowards …
Ken Moch, I can only hope this doesn’t
happen to your child.” And Moch was
the target of death threats that the
FBI deemed credible, so he and his
wife moved out of their home for
several days.
Under intense pressure, the
company worked out a plan with the
Food and Drug Administration to add a
clinical trial for the drug, brincidofovir,
and to enroll Josh as its first patient.
“It was relatively an easier campaign
because we had a very tangible goal,”
says William Burns, Josh’s uncle, who
first used the hashtag and set up the
“Save Josh” Facebook page. “We had
an immediate need, not like, ‘Give
more money to cure cancer 10 years
from now.’ ”
The CEO Who
Saved a Life and
Lost His Job
Former Chimerix
CEO Moch
19
DATA: SYSOMOS
32,478
Last Resort
Requests granted by the FDA for compassionate use
of a drug, in the 12 months ended Sept. 30
While the question of whether to
give Josh the drug seemed like a nobrainer
to his family and supporters,
it presented Chimerix with tricky
issues to sort out. Compassionate use—formally
known as expanded access—
allows experimental
drugs that haven’t
been approved by the FDA to be given
to patients in life-
or-death situations
who have no other treatment options.
While the FDA is required to sign off
on compassionate-use cases—it usually
approves about 1,000 a year—the decision
about whether to give out an unapproved
drug rests with drugmakers. A
patient’s physician typically requests a
drug from the company developing it.
The company weighs several factors,
including the most potentially tragic—
that the drug might hasten or cause
the death of a patient. Such a death
can complicate a company’s efforts to
secure FDA approval and to ultimately
make the drug widely available.
For a small biotech like Chimerix,
which had no product on the market
and no source of revenue, handing out
experimental
drugs, usually for free, can
be especially costly. Compassionate use
also can delay the FDA approval process,
because drugs and other resources are
diverted to patients who aren’t enrolled
in formal trials, which collect data necessary
for gaining regulatory approval.
“Everyone asks this question,” Moch
says. “ ‘If it were my child, would I do
what the Hardys did?’ Absolutely, yes. ”
But that wasn’t his role, he says. “As the
CEO, I have to think not just about the
individual, but the many.”
On April 9, three weeks after Josh
got into the brincidofovir trial, Moch
stepped down as CEO. The company
says he resigned. Moch says he was
replaced and can’t comment in detail
about his departure other than to say
he would have “loved to continue to
be CEO, but the board felt otherwise.”
Chimerix declined to comment beyond
its press release announcing Moch’s
departure and his replacement. “We are
now entering a critical stage of the clinical
development of brincidofovir,” the
release said. “Our goal is to complete the
requirements for regulatory approval of
brincidofovir as rapidly as possible.”
Moch, 60, joined Chimerix as CEO
in 2010. He studied biochemistry as an
undergraduate at Princeton and had
worked in the life sciences industry since
getting his MBA from Stanford in 1980. In
1982 he co-founded Liposome, a developer
of treatments for cancer, including
breast cancer; drugmaker Elan acquired
Liposome in 2000. Moch held various
executive-
level positions with medical
companies before joining Chimerix.
Last year, when Chimerix was
approached for help by the Hardy
family, the company had 55 employees,
no approved drugs, and was relying on
funds from investors. It was in the final
phase of testing brincidofovir for FDA
approval to market the drug to prevent
cytomegalovirus in bone marrow stem
cell transplant patients. Chimerix also
had tested brincidofovir as a preventive
therapy for adenovirus, the virus
afflicting Josh, in an earlier stage of
the trial. At the end of March 2014, the
company had an accumulated deficit of
$173 million since its founding in 2000,
according to regulatory filings.
Chimerix had previously given
brincidofovir
to 430 patients for compassionate
use in a program funded in
part by the government. When funding
ran out in 2012, Chimerix closed the
program to focus on getting the drug
through the FDA, Moch says. Allocating
any available doses to Josh could have
slowed that process, he says. “It’s horribly
conflicting,” he says of the dilemma
he faced in March. “You go into this
business to saves lives.”
Some patient advocates insist that
companies have a moral obligation to
make their drugs available to desperately
ill patients. “Here’s a kid where it’s
life or death, hanging on to Ken Moch’s
decision,” says Nancy Goodman, executive
director of Kids v Cancer, a nonprofit
advocacy group for children with cancer
which helped publicize the Hardy family’s
campaign. “It’s profoundly unethical
for him not to give the drug.”
Kevin Donovan, director of the
Center for Clinical Bioethics at the
Georgetown University Medical Center,
says the conflict between companies
and patients lies in a clash of responsibilities.
“The company’s obligation
is the greatest good for the greatest
number,” he says. “If it’s your loved
one, if it’s you, if you’re a patient, your
moral obligation is to the welfare of
that individual.” Both approaches are
legitimate, he says.
These complexities get lost in a
social media maelstrom, says Darshak
Sanghavi, an associate professor at the
University of Massachusetts Medical
School who’s conducted research on
compassionate-use issues. “I think that
whenever you have 140 characters to
describe a complicated medical decision,
it’s going to be oversimplified—
‘there’s a dying child, why won’t the
drug company give the drug?’ ” Sanghavi
says. “It’s so easily amplified, and any
nuance, even if it was present early on,
rapidly gets rubbed out,” he says.
James Greenwood, CEO of the
Biotechnology Industry Organization
(BIO), says social media’s role in
the Hardy case unnerved the industry.
“When you add social media and
start tweeting
all over the place, then
reason flies out of the window,” says
Greenwood. “Social media creates
opinion storms, we all know that.”
Moch stresses that in the end, Josh’s
brincidofovir treatment was not
compassionate
use. As part of a new
clinical trial, his response to the drug
was included in data Chimerix was
gathering in its push for FDA approval.
The trial tested brincidofovir
as a
treatment for adenovirus, not just a
preventive
therapy. Barring any delays,
the FDA could approve the drug by the
end of 2016.
Moch’s point is one that matters
deeply to small biotech companies
trying to get their first drug to market.
One example, says BIO’s Greenwood,
is CytRx, a biotech whose trials for its
experimental
cancer drug aldoxorubicin
were temporarily placed on hold
on Nov. 18 after the death of a patient
who received the medication under
compassionate use. The potential for
the FDA to stop a trial because of a
tweets worldwide using #savejosh
from Jan. 16, 2014, to Jan. 16, 2015
2k
1k
0
*12 MONTHS ENDED OCT. 12
DATA: FOOD AND DRUG ADMINISTRATION
57%
Urgent requests on
behalf of patients who
could die within hours
2010* 2011* 2012 2013 2014
20
Companies/Industries
CLOCKWISE FROM TOP LEFT: COURTESY YOUTUBE;COURTESY ROCKETJUMP; COURTESY FYI; KARWAI TANG/WIREIMAGE/GETTY IMAGES;
FRANCOIS GUILLOT/AFP/GETTY IMAGES
Kravitz. Yet that star power isn’t deterring
YouTube from offering its own
halftime show online, hosted by Harley
Morenstein, the ringleader of food
stunt group Epic Meal Time. In 2010,
Morenstein and his pals made history
when they wowed Web viewers with
a 5,210 calorie pizza made of fast-food
items (boasting 286 grams of fat). In
addition to music, he promises
fake Super Bowl ads and
stunts such as online celebrities
jumping into a vat of cheese.
The show, featuring some
of YouTube’s biggest stars, is
part of a broader initiative to
promote ads on the Googleowned
site—as well as to exploit
The Other Super Bowl Contest
YouTube’s quirky, alternative halftime show will challenge NBC’s
pop star-studded extravaganza
Kravitz, a four-time
Grammy awardee,
has also appeared
in two Hunger
Games films
Wong’s main
channel on
YouTube has more
than 7.4 million
subscribers
Turner’s offbeat
antics have helped
draw 3.2 billion
video views to his
three channels
Entertainers
Katy Perry
Lenny Kravitz
Typical Ad Price
$4.5m 30-second spot
Demographic
Anyone breathing
Viewers of 2014
halftime show
115.3m
Viewers who tuned in to
2014 halftime show but
skipped the game
3.8m
Entertainers
Harley Morenstein
Freddie Wong
Toby Turner
Kurt Hugo Schneider
Smosh Games
FouseyTUBE
Matt Santoro
MysteryGuitarMan
Typical ad price
$9.11 per 1,000 views
Demographic
18-34 year olds
Subscribers to the acts
in YouTube’s show
60m
patient death or some adverse event
outside the scope of a trial, for which
patients are carefully screened, could
further deter biotechs from giving out
their drugs, Greenwood says.
BIO is working with its member
companies, particularly small ones,
to prepare for campaigns like the
one the Hardy family waged against
Chimerix and Moch. The group suggests
that members make it clear how a
compassionate-
use program will operate
and develop a crisis management plan.
About a week after receiving
brincidofovir,
Josh’s mother reported
on her blog that his condition had
improved dramatically; he was discharged
from the hospital in early
April. Moch says he’s in active discussions
to take a new CEO job. He’s spent
the past nine months meeting regularly
with chief executives of other
small companies about compassionate
use issues and consulting for a
working group of ethicists at New York
University’s Langone Medical Center
that’s studying the challenges of compassionate
use.
“For the biotech community, what
happened to Moch was a shock,” says
Greenwood. “Within the BIO board
and in our community, Ken Moch is a
very loved person. People were hurt
to see what happened to him, and
they worried that this could be me.”
Caroline Chen
The bottom line Biotechs have watched
closely the experience of Chimerix, the target
of a social media campaign.
NBC
YouTube
Media
YouTube Wants to Be a
Super Bowl Winner, Too
▶▶The site’s alternative halftime show
is a bid to win advertisers’ attention
▶▶Figuring “what was Freddie Wong’s
draw compared to Katy Perry”
The Super Bowl halftime show has
become a showcase for some of music’s
biggest stars in recent years, from Paul
McCartney and the Rolling Stones to
Beyoncé, Prince, and Madonna. True
to form, this year’s broadcast, on Feb. 1
on Comcast’s NBC, will feature singer
Katy Perry, one of pop music’s biggest
acts, with an assist by rocker Lenny
“YouTube is the
place where
people go to
consume
advertisements
willingly. It’s some
capitalist
dystopian
nightmare.”
——Freddie Wong
America’s cult of loving and hating the
expensive ads that air during the Super
Bowl, the year’s most-watched television
event. Last year’s game, broadcast on
Fox, was seen by more than 111.5 million
viewers, a record. The YouTube spectacle
will stream live on its website during
the game. YouTube has long competed
for video advertising dollars with
Facebook and Twitter, and it
will use the halftime show and
the ads around it to differentiate
itself and demonstrate its
value to top brands.
YouTube says the growing
profile of its stars like Freddie
Wong, whose main channel
has more than 7.4 million
Cooking stunt
auteur Morenstein
will host
YouTube’s
halftime show
Perry was No. 1 on
Billboard’s Hot 100
list of artists in 2014
21
Copyright of Bloomberg Businessweek is the property of Bloomberg, L.P. and its content
may not be copied or emailed to multiple sites or posted to a listserv without the copyright
holder’s express written permission. However, users may print, download, or email articles for
individual use.
Business & Society
Ethics, Sustainability, and Stakeholder Management
TENTH EDITION
ARCHIE B . CARROLL
University of Georgia
J I L L A . BROWN
Bentley University
ANN K. BUCHHOLTZ
Rutgers University
Australia • Brazil • Mexico • Singapore • United Kingdom • United States
Copyright 2018
Science is the pursuit and application of knowledge and understanding of the natural and social…
Clearly stating the definition, the values, the meaning of such values and the type of…
All answered must be typed using Times New Roman (size 12, double-spaced) font. No pictures…
All answered must be typed using Times New Roman (size 12, double-spaced) font. No pictures…
https://www.npr.org/sections/ed/2018/04/25/605092520/high-paying-trade-jobs-sit-empty-while-high-school-grads-line-up-for-university Click on the link above. Read the entire link and answer the questions below…
All answered must be typed using Times New Roman (size 12, double-spaced) font. No pictures…